Insider · CIK 0001658379

Coleman Mark

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001658379

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−643 sh	$249.00	−$160K	30,389
2026-06-08	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,429 sh	—	—	31,032
2026-06-08	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,429 sh	—	—	0
2026-06-05	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+1,721 sh	—	—	1,721
2026-06-02	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−5,537 sh	$223.39	−$1.24M	29,603
2026-06-01	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−6,000 sh	$230.30	−$1.38M	35,140
2026-05-29	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−6,000 sh	$233.46	−$1.4M	41,140
2026-02-26	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−25K sh	$161.11	−$4.03M	47,140
2026-02-23	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,250 sh	$4.95	+$30.9K	72,140
2026-02-23	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,250 sh	—	—	7,721
2026-02-20	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+12.5K sh	$4.95	+$61.8K	65,890
2026-02-20	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−12.5K sh	—	—	13,971
2026-02-10	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,193 sh	$8.02	+$41.6K	53,405
2026-02-10	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,193 sh	—	—	0
2025-09-08	AXSMAxsome Therapeutics, Inc.P Purchase	Director	PPurchase	+800 sh	$127.20	+$102K	47,437
2025-09-08	AXSMAxsome Therapeutics, Inc.P Purchase	Director	PPurchase	+287 sh	$127.30	+$36.5K	47,724
2025-09-08	AXSMAxsome Therapeutics, Inc.P Purchase	Director	PPurchase	+488 sh	$127.40	+$62.2K	48,212
2025-06-06	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,166 sh	—	—	3,166
2025-06-06	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+1,429 sh	—	—	1,429
2025-05-28	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−3,750 sh	$103.43	−$388K	46,637
2025-05-27	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−3,750 sh	$105.47	−$396K	50,387
2025-05-20	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−3,000 sh	$107.49	−$322K	54,137
2025-01-03	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,127 sh	$9.00	+$82.1K	57,137
2025-01-03	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,127 sh	—	—	0
2024-11-19	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+33.4K sh	$5.94	+$198K	48,010
2024-11-19	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−33.4K sh	—	—	0
2024-06-07	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,799 sh	—	—	5,799
2024-05-29	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−5,248 sh	$75.14	−$394K	14,600
2024-05-28	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−5,249 sh	$75.21	−$395K	19,848
2023-09-15	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11K sh	$3.67	+$40.4K	36,113
2023-09-15	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−11K sh	$75.19	−$828K	25,097
2023-09-15	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−18.6K sh	$75.18	−$1.4M	403,856
2023-09-15	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−11K sh	—	—	0
2023-06-02	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,681 sh	—	—	5,681
2023-03-02	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,870 sh	—	—	2,870
2023-01-03	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+17.5K sh	$1.30	+$22.8K	25,097
2023-01-03	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−17.5K sh	—	—	0
2022-06-03	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	16,976
2022-03-15	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,496 sh	$1.30	+$4,544.8	7,596
2022-03-15	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,496 sh	—	—	17,501
2022-03-04	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,798 sh	—	—	2,798
2021-11-18	AXSMAxsome Therapeutics, Inc.P Purchase	Director	PPurchase	+409 sh	$35.07	+$14.3K	421,407
2021-11-18	AXSMAxsome Therapeutics, Inc.P Purchase	Director	PPurchase	+1,021 sh	$35.10	+$35.8K	422,428
2021-06-04	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,325 sh	—	—	7,325
2021-05-12	AXSMAxsome Therapeutics, Inc.P Purchase	Director	PPurchase	+500 sh	$58.15	+$29.1K	420,998
2021-03-05	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,201 sh	—	—	1,201
2020-08-19	AXSMAxsome Therapeutics, Inc.G Gift	Director	GGift	−398K sh	—	—	5,700
2020-08-19	AXSMAxsome Therapeutics, Inc.G Gift	Director	GGift	+398K sh	—	—	397,998
2020-06-29	AXSMAxsome Therapeutics, Inc.P Purchase	Director	PPurchase	+650 sh	$78.50	+$51K	403,698
2020-06-05	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000

Recent filings

Accepted (ET)
Jun 104
Coleman Mark0001193125-26-266433
SEC(opens sec.gov)
Jun 94
Coleman Mark0001193125-26-264041
SEC(opens sec.gov)
Jun 24
Coleman Mark0001193125-26-254038
SEC(opens sec.gov)
Feb 274
Coleman Mark0001193125-26-083587
SEC(opens sec.gov)
Feb 254
Coleman Mark0001193125-26-072481
SEC(opens sec.gov)
Feb 234
Coleman Mark0001193125-26-064681
SEC(opens sec.gov)
Feb 104
Coleman Mark0001193125-26-045110
SEC(opens sec.gov)
Sep 94
Coleman Mark0000950170-25-113874
SEC(opens sec.gov)
Jun 104
Coleman Mark0000950170-25-084560
SEC(opens sec.gov)
May 294
Coleman Mark0000950170-25-079229
SEC(opens sec.gov)

Companies

Axsome Therapeutics, Inc.DirectorAXSM

Address

C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 29TH FLOOR

NEW YORK, NY, 10007